← Back to markets
Crinetics Pharmaceuticals
CRNX · Health Care · Pharmaceuticals
$84.08+0.2%
RS +51.5
Returns
| 7D | +0.7% |
| 1M | +0.6% |
| 3M | +93.3% |
| 6M | +87.7% |
| YTD | +80.6% |
| 1Y | +194.7% |
About Crinetics Pharmaceuticals
Crinetics Pharmaceuticals is a global pharmaceutical company known for developing drugs for the treatment of endocrine-related diseases. It was founded by Scott Struthers, Frank Zhu, Ana Kusnetzow, and Stephen F. Betz in 2008 and is headquartered in San Diego, California. It went public on NASDAQ in 2018.